933695-45-5

Basic information

• Product Name: 2-(HYDROXYCYCLOBUTYL)ACETIC ACID
• Synonyms: 2-(HYDROXYCYCLOBUTYL)ACETIC ACID;2-(1-Hydroxycyclobutyl)Acetic Acid;2-(1-Hydroxycyclobutyl)Acetic Acid(WX610394)
• CAS NO: 933695-45-5
• Molecular Formula: C6H10O3
• Molecular Weight: 130.1418
• Mol File: 933695-45-5.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-(HYDROXYCYCLOBUTYL)ACETIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(HYDROXYCYCLOBUTYL)ACETIC ACID(933695-45-5)
• EPA Substance Registry System: 2-(HYDROXYCYCLOBUTYL)ACETIC ACID(933695-45-5)

Safety Data

• Hazardous Substances Data: 933695-45-5(Hazardous Substances Data)

Usage

Description

2-(Hydroxycyclobutyl)acetic acid, also known as hydroxycyclobutylacetic acid, is a carboxylic acid derivative with a molecular formula C6H10O3. It features a hydroxyl group and a cyclobutyl ring structure, making it a unique compound with potential applications in organic synthesis and pharmaceutical research.

Uses

Used in Organic Synthesis:
2-(Hydroxycyclobutyl)acetic acid is used as a building block for the synthesis of various organic compounds due to its unique structural features.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2-(Hydroxycyclobutyl)acetic acid is used as a key intermediate in the development of new pharmaceuticals, leveraging its distinctive chemical properties to create innovative medications.

Upstream product

• 27784-32-3 ethyl 2-(1-hydroxycyclobutyl)acetate 

Relevant articles and documents

ALCOHOL DERIVATIVES AS KV7 POTASSIUM CHANNEL OPENERS FOR USE IN EPILEPSY OR SEIZURES

The present invention provides novel compounds which activate the Kv7 potassium channels. Separate aspects of the invention are directed to pharmaceutical compositions comprising said compounds and uses of the compounds to treat disorders responsive to the activation of Kv7 potassium channels.

ALCOHOL DERIVATIVES AS KV7 POTASSIUM CHANNEL OPENERS

The present invention provides novel compounds which activate the Kv7 potassium channels. Separate aspects of the invention are directed to pharmaceutical compositions comprising said compounds and uses of the compounds to treat disorders responsive to the activation of Kv7 potassium channels.

NOVEL BENZODIOXOLE PIPERIDINE COMPOUNDS

The present invention is concerned with novel dual modulators of the 5-HT2A and D3 receptors of formula (I) wherein n, Y, R1, R2, R3, and R4 are as described herein, as well as pharmaceutically acceptable salts and esters thereof. Further the present invention is concerned with the manufacture of the compounds of formula (I), pharmaceutical compositions comprising them and their use as medicaments.